Brooklyn Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.1M Buy
21,894
+4,471
+26% +$4.53M 0.63% 22
2025
Q4
$18.8M Buy
17,423
+7,062
+68% +$6.75M 0.87% 13
2025
Q3
$8.03M Sell
10,361
-311
-3% -$231K 1.09% 11
2025
Q2
$6.83M Buy
10,672
+3,791
+55% +$2.95M 0.9% 11
2025
Q1
$5.68M Buy
6,881
+1,685
+32% +$1.4M 1.23% 11
2024
Q4
$4.01M Sell
5,196
-443
-8% -$367K 1.2% 13
2024
Q3
$5M Buy
5,639
+404
+8% +$363K 1.64% 8
2024
Q2
$3.98M Hold
5,235
1.71% 9
2024
Q1
$3.98M Buy
5,235
+387
+8% +$275K 1.71% 9
2023
Q4
$2.83M Buy
+4,848
New +$2.83M 1.35% 13

Other funds holding LLY

Brooklyn Investment Group's LLY Position: Q1 2026 in Review

Brooklyn Investment Group increased its Eli Lilly (LLY) stake by 26% in Q1 2026, buying an estimated $4.53M and bringing the position to 21,894 shares worth $20.1M. The position accounts for 0.63% of the portfolio, ranked #22.

Brooklyn Investment Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Brooklyn Investment Group held 21,894 shares of Eli Lilly worth $20.1M as of Q1 2026.
  • Brooklyn Investment Group bought 4,471 Eli Lilly shares in Q1 2026, an estimated $4.53M.
  • Eli Lilly made up 0.63% of Brooklyn Investment Group's portfolio in Q1 2026, its #22 holding.
  • Brooklyn Investment Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.